The novel adrenergic agonist ATR-127 targets skeletal muscle and brown adipose tissue to tackle diabesity and steatohepatitis.

Both insulin and clenbuterol increased skeletal muscle glucose uptake ( Figure 2 F) and a tendency to increased glucose uptake was observed for ATR-127, though did not reach statistical significance, probably due to lack of power. 2.3.

also in 111,027 other papers